南韩新增985宗确诊 向辉瑞与杨森采购1,600万剂疫苗
韩国中央防疫对策本部公布,截至24日凌晨新增确诊个案985案,累计确诊增至53,533宗,单日死亡个案增加17宗,累计增至756宗。
韩国国务总理丁世均透露,将向杨森制药采购600万剂疫苗,明年第二季度开始接种,并从辉瑞(PFE.US)药厂采购1,000万剂疫苗,明年第三季度交付,目前正在与辉瑞协商,争取提前於第二季到货。
当地政府自24日起至明年1月3日实施「圣诞元旦假期特别防疫措施」,禁止5人以上订座或同时前往餐厅聚餐,同时全面叫停滑雪场等冬季体育设施的运营,并关闭日出旅游景点。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.